Previous research has shown that ASCs from SLE patients exhibit increased expression of genes associated with survival, proliferation, and antibody production, including cytokines such as IL-6 and IL-10, adhesion molecules, and components of the B-cell receptor (BCR) signaling pathway. The gene discussed is BCR; the disease is systemic lupus erythematosus.